Massachusetts Financial Services Co. MA purchased a new position in shares of Tenet Healthcare Co. (NYSE:THC – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 17,075 shares of the company’s stock, valued at approximately $2,155,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of THC. Norges Bank acquired a new stake in shares of Tenet Healthcare during the fourth quarter valued at about $190,819,000. Wealthfront Advisers LLC acquired a new stake in Tenet Healthcare during the 4th quarter worth approximately $69,059,000. Geode Capital Management LLC increased its position in Tenet Healthcare by 23.6% in the 3rd quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company’s stock valued at $339,893,000 after acquiring an additional 390,316 shares during the period. Raymond James Financial Inc. bought a new position in shares of Tenet Healthcare during the fourth quarter valued at $49,001,000. Finally, Victory Capital Management Inc. increased its holdings in Tenet Healthcare by 68.9% in the fourth quarter. Victory Capital Management Inc. now owns 507,055 shares of the company’s stock valued at $64,006,000 after purchasing an additional 206,907 shares during the period. Institutional investors own 95.44% of the company’s stock.
Insider Activity at Tenet Healthcare
In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the company’s stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares in the company, valued at $3,434,022.54. This represents a 25.81 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.93% of the stock is currently owned by company insiders.
Tenet Healthcare Trading Down 0.3 %
Tenet Healthcare (NYSE:THC – Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share for the quarter, beating analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. On average, analysts predict that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several brokerages have recently weighed in on THC. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $175.00 price target on shares of Tenet Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a report on Thursday, February 13th. TD Cowen initiated coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They issued a “buy” rating and a $175.00 price objective on the stock. KeyCorp cut their price target on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Truist Financial lowered their price objective on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Three research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare currently has an average rating of “Moderate Buy” and an average price target of $166.41.
View Our Latest Stock Report on Tenet Healthcare
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Articles
- Five stocks we like better than Tenet Healthcare
- Canadian Penny Stocks: Can They Make You Rich?
- Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential
- What Do S&P 500 Stocks Tell Investors About the Market?
- Qualcomm Breaks Down But RSI Signals It’s Severely Oversold
- Consumer Discretionary Stocks Explained
- Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.